The Digest’s 2025 Multi-Slide Guide to Twist Bioscience
by Jim Lane (Biofuels Digest) Twist Bioscience aims for $1 billion in revenue and is crossing the threshold to Adjusted EBITDA breakeven, reporting Q2 FY2025 revenue of $92.8M. The company emphasizes continued product innovation, including mRNA and milligram scale plasmid, and